ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases
NCT05018702
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
32
Enrollment
OTHER
Sponsor class
Conditions
HER2-positive, Metastatic Breast Cancer
Interventions
DRUG:
ARX788
Sponsor
Fudan University